Wolf Administration Announces Leader in Regenerative Medicine to Expand Operations in Allegheny County, Creating 64 New Jobs

September 24, 2015

Harrisburg, PA – Governor Tom Wolf announced today that Cook MyoSite, Inc., a clinical stage biotech firm specializing in human cell regeneration, will expand its operations in O’Hara Township, Allegheny County and will create 64 new, full-time jobs.

“Founded in Pittsburgh from research conducted at the University of Pittsburgh, today’s announcement showcases everything that Pennsylvania has to offer to businesses,” Governor Wolf said. “The work Cook MyoSite is doing is changing lives, and we are proud to support this expansion in Pennsylvania.”

Cook MyoSite will expand operations by renovating an adjacent 62,000-square-foot building into the new headquarters. The company plans to invest at least $26 million on the project and has also committed to the creation of 64 new, full-time jobs and the retention of 75 current positions over the next three years.

Cook MyoSite received a funding proposal from the Department of Community and Economic Development that includes a $100,000 Pennsylvania First Program grant and $28,800 in WEDnetPA grant funding.

“The facility will be a new manufacturing location for global distribution of a biopharmaceutical product that uses a patient’s own muscle cells to create a specialized treatment for numerous disease states,” said Stephen Westover, Director of Quality. Cook MyoSite is expanding into new countries, new clinical trials, and now new buildings. With this growth, Cook MyoSite currently employs 75 people and is hiring additional employees.”

The project was coordinated by the Governor’s Action Team, an experienced group of economic development professionals who report directly to the governor and work with businesses that are considering locating or expanding in Pennsylvania.

A leader in regenerative medicine, Cook MyoSite was formed in 2002 by Cook Medical to guide the company into the expanding world of cellular technologies. Through pioneering efforts, research involving the use of adult skeletal muscle-derived cells for tissue augmentation is being developed into a treatment option for patients with a variety of muscle-related disorders.

For further information on Cook MyoSite, Inc., visit www.cookmyosite.com.

For more information about the Governor’s Action Team, visit www.newpa.com.


SHARE Email Facebook Twitter